Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.8567
-0.0444 (-4.93%)
At close: Oct 2, 2026, 4:00 PM EDT
0.8907
+0.0340 (3.97%)
After-hours: Oct 2, 2026, 7:59 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $154.28 million as of October 2, 2026. Its market cap has decreased by -73.24% in one year.
Market Cap
154.28M
Enterprise Value
-15.96M
1-Year Change
-73.24%
Ranking
Category
Stock Price
$0.86
ChartMarket Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $154.28M, a decrease of -64.56%. That is a compound annual growth rate of -17.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 154.28M | -83.85% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 161.83M |
| Veraxa Biotech AG | 159.79M |
| Protara Therapeutics | 159.56M |
| PepGen | 157.91M |
| NovaBridge Biosciences | 157.18M |
| Minerva Neurosciences | 156.61M |
| Molecular Partners AG | 153.82M |
| Tonix Pharmaceuticals Holding | 152.82M |